MedPath

CKD-581

Generic Name
CKD-581

CKD-581 + Bortezomib + Dexamethasone in Patients With Previously Treated Multiple Myeloma

Phase 1
Conditions
Myeloma, Multiple
Interventions
First Posted Date
2017-02-14
Last Posted Date
2020-02-24
Lead Sponsor
Chong Kun Dang Pharmaceutical
Target Recruit Count
18
Registration Number
NCT03051841
Locations
🇰🇷

Seoul National University Hospital, Seoul, Korea, Republic of

Safety and Pharmacokinetic Profile of CKD-581

Phase 1
Completed
Conditions
Multiple Myeloma
Lymphoma
Interventions
First Posted Date
2012-04-19
Last Posted Date
2016-10-06
Lead Sponsor
Chong Kun Dang Pharmaceutical
Target Recruit Count
39
Registration Number
NCT01580371
Locations
🇰🇷

ASAN Medical Center, Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath